These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 17485579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH.
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2006 Jul 11; 114(2):135-42. PubMed ID: 16818817
    [Abstract] [Full Text] [Related]

  • 6. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT, Pai SM, Timothy P, Pai RG.
    Pacing Clin Electrophysiol; 2005 Jul 11; 28(7):647-53. PubMed ID: 16008799
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM, Zhang S, Chen KP, Hua W, Wang FZ, Chen X.
    Chin Med J (Engl); 2009 Apr 05; 122(7):802-6. PubMed ID: 19493393
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E, Trinquart L, Otmani A, Waintraub X, Kacet S, Clémenty J, Chatellier G, Le Heuzey JY, Evaluation Médico-Economique du Défibrillateur Automatique Implantable (EVADEF) Investigators.
    Am Heart J; 2009 Feb 05; 157(2):391-397.e1. PubMed ID: 19185651
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul 05; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

  • 14. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
    Grimm W, Alter P, Maisch B.
    Herz; 2004 May 05; 29(3):348-52. PubMed ID: 15167963
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
    Marijon E, Trinquart L, Otmani A, Leclercq C, Fauchier L, Chevalier P, Klug D, Defaye P, Lellouche N, Mansourati J, Deharo JC, Sadoul N, Anselme F, Maury P, Davy JM, Extramiana F, Hidden-Lucet F, Probst V, Bordachar P, Mansour H, Chauvin M, Jouven X, Lavergne T, Chatellier G, Le Heuzey JY, EVADEF Investigators.
    Am Heart J; 2010 Apr 05; 159(4):659-664.e1. PubMed ID: 20362726
    [Abstract] [Full Text] [Related]

  • 17. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
    Singh SN, Poole J, Anderson J, Hellkamp AS, Karasik P, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Am Heart J; 2006 Nov 05; 152(5):974.e7-11. PubMed ID: 17070171
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W, Christ M, Bach J, Müller HH, Maisch B.
    Circulation; 2003 Dec 09; 108(23):2883-91. PubMed ID: 14623812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.